ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,268.05
-3.46%
US Tech 100
17,847.20
0.00%
다우존스 지수
39,593.66
-2.50%
Bitcoin
80,850.67
1.54%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Wave Life Sciences Ltd (WVE) 시세

Wave Life Sciences Ltd

Wave Life Sciences Ltd (WVE)

NASDAQ
5.48
0.00
(0.00%)
마감 11 4월 5:00AM
15분 지연
0.00
0.00
(0.00%)
시간외 거래: -
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
5.48
매수가
5.07
매도가
6.24
거래량
-
0.00 일간 변동폭 0.00
4.25 52주 범위 16.735
market_cap
841.103M
전일 종가
5.48
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
1,188,468
발행 주식
153,486,021
배당수익률
-
주가수익률
-8.67
주당순이익(EPS)
-0.63
매출
111.53M
순이익
-97.01M

Wave Life Sciences Ltd 정보

WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic def... WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.wavelifesciences.com
본부
Singapore, Sgp
설립됨
-
Wave Life Sciences Ltd is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker WVE. The last closing price for Wave Life Sciences was US$5.48. Over the last year, Wave Life Sciences shares have traded in a share price range of US$ 4.25 to US$ 16.735.

Wave Life Sciences currently has 153,486,021 shares in issue. The market capitalisation of Wave Life Sciences is US$841.10 million. Wave Life Sciences has a price to earnings ratio (PE ratio) of -8.67.

WVE 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
26 3월 2025
WVE (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 3월 2025
WVE (0.00%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
08 3월 2025
WVE (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 3월 2025
WVE (0.00%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
04 3월 2025
WVE (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
04 3월 2025
WVE (0.00%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-1.22-18.20895522396.76.765.2819927045.83321455CS
4-4.91-47.256977863310.3910.915.2815987557.8538744CS
12-5.91-51.887620719911.3912.525.2811884689.44826433CS
26-2.75-33.41433778868.2316.7355.28132046312.18126552CS
52-0.56-9.271523178816.0416.7354.2511661009.72702051CS
1563.12132.2033898312.3616.7351.167472557.17156591CS
260-2.33-29.8335467357.8119.981.167001547.43425227CS

WVE - Frequently Asked Questions (FAQ)

What is the current Wave Life Sciences share price?
The current share price of Wave Life Sciences is US$ 5.48
How many Wave Life Sciences shares are in issue?
Wave Life Sciences has 153,486,021 shares in issue
What is the market cap of Wave Life Sciences?
The market capitalisation of Wave Life Sciences is USD 841.1M
What is the 1 year trading range for Wave Life Sciences share price?
Wave Life Sciences has traded in the range of US$ 4.25 to US$ 16.735 during the past year
What is the PE ratio of Wave Life Sciences?
The price to earnings ratio of Wave Life Sciences is -8.67
What is the cash to sales ratio of Wave Life Sciences?
The cash to sales ratio of Wave Life Sciences is 7.54
What is the reporting currency for Wave Life Sciences?
Wave Life Sciences reports financial results in USD
What is the latest annual turnover for Wave Life Sciences?
The latest annual turnover of Wave Life Sciences is USD 111.53M
What is the latest annual profit for Wave Life Sciences?
The latest annual profit of Wave Life Sciences is USD -97.01M
What is the registered address of Wave Life Sciences?
The registered address for Wave Life Sciences is 8 CROSS STREET #10-00�����, PWC BUILDINGE, SINGAPORE, 018936
What is the Wave Life Sciences website address?
The website address for Wave Life Sciences is www.wavelifesciences.com
Which industry sector does Wave Life Sciences operate in?
Wave Life Sciences operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 65.94
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.05
(0.00%)
0
AACGATA Creativity Global
US$ 0.91
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.07
(0.00%)
0
AACBArtius II Acquisition Inc
US$ 9.89
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 65.94
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.05
(0.00%)
0
AACGATA Creativity Global
US$ 0.91
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.07
(0.00%)
0
AACBArtius II Acquisition Inc
US$ 9.89
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 65.94
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.05
(0.00%)
0
AACGATA Creativity Global
US$ 0.91
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.07
(0.00%)
0
AACBArtius II Acquisition Inc
US$ 9.89
(0.00%)
0

WVE Discussion

게시물 보기
TechandBio TechandBio 4 주 전
Are these RNA editing indications even necessary with regular RNAI-SIRNA drug pipeline of 450 drugs seems like most of these editing drugs like gene editing are all flops companies not sure about RNA Editing when companies like ALNY and Novartis have the goods to make good old fashion Sirna drugs

$WVE
👍️0
TechandBio TechandBio 4 주 전
https://fintel.io/i/m28-capital-management-lp


Top Increases This Quarter

We use the change in the portfolio allocation because this is the most meaningful metric. Changes can be due to trades or changes in share prices.


WVE / Wave Life Sciences Ltd. 5.66 70.07 68.7941 13.2486
TGTX / TG Therapeutics, Inc. 0.16 4.86 4.7756 0.6221
PRQR / ProQR Therapeutics N.V. 1.02 2.70 2.6525 0.6136
SWTX / SpringWorks Therapeutics, Inc. 0.11 3.99 3.9161 0.0293


almost 70% of M28 Capital is in WVE that is lead and advised John Maraganore, PhD. Alnylam Pharmaceuticals. Cambridge, MA. Brook ... M28 Capital Management.

$WVE
👍️0
PonkenPlonken PonkenPlonken 3 월 전
👍️0
TechandBio TechandBio 4 월 전
Will wait for buyout on my $6.80 average here.

$WVE
👍️0
TechandBio TechandBio 5 월 전
RNAI stocks are going to be the biggest driver in biotech in the through 2030 WAVE and PRQR
These could be the next ALNY
450 drugs in the pipeline worldwide for RNAI drugs.

$WVE
👍️0
boston127 boston127 6 월 전
Gotta love their business.

If their RNA model works, it could have fantastic results for humanity.
👍️0
PonkenPlonken PonkenPlonken 6 월 전
Finally,,,,,,,, "they" will water them all and things will get going. RNA in genetic diseases....
👍️0
PonkenPlonken PonkenPlonken 6 월 전
beautiful....
👍️0
Awl416 Awl416 6 월 전
Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
👍️0
TechandBio TechandBio 6 월 전
WVE Can't wait for the Phase 1 Obesity indication to commence later this year or early 2025 thats the icing on the cake.

$WVE
👍️0
PonkenPlonken PonkenPlonken 6 월 전
can you say breakout?
👍️0
PonkenPlonken PonkenPlonken 6 월 전
why claim this afterwards? Pointless
👍️0
TechandBio TechandBio 6 월 전
Poetry in Motion!

$WVE
👍️0
TechandBio TechandBio 7 월 전
Solid looking for more!

Glad I doubled up last week!

$WVE
👍️0
PonkenPlonken PonkenPlonken 7 월 전
wowser there it is

Dystrophin results from a pre-specified analysis of ambulatory boys showed:
Mean absolute muscle content-adjusted dystrophin expression was 9.0% (range: 4.6-13.9%) and mean absolute unadjusted dystrophin expression was 5.5% of normal (range: 3.3-8.3%), as measured by Western Blot.
[...]
89% of ambulatory participants achieved muscle content-adjusted dystrophin levels of at least 5%.
👍️ 1
Monksdream Monksdream 7 월 전
WVE under $7
👍️0
Monksdream Monksdream 9 월 전
WVE under $10
👍️0
PonkenPlonken PonkenPlonken 9 월 전
one of the singaporean companies that does not look like a scam but rather like singaporean excellence.
👍️0
Monksdream Monksdream 11 월 전
WVE under $10
👍️0
Monksdream Monksdream 1 년 전
WVE new 52 week high
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
WVE...BEAUTIFUL WEEKLY
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
WVE...BIO MONSTER SETTING UP
👍️0
PRIVATE SHAREHOLDER PRIVATE SHAREHOLDER 2 년 전
Big clinical news coming shortly
👍️0
PRIVATE SHAREHOLDER PRIVATE SHAREHOLDER 2 년 전
Company reporting big news next week. Stay tuned!
👍️0
MiamiGent MiamiGent 2 년 전
WVE stretched out this morning!

WAVE LIFE SCIENCES LTD
$5.24 +$0.20 (+3.97%)

WVE is a real stock!

https://stockcharts.com/h-sc/ui?s=WVE
👍️0

최근 히스토리

NASDAQ
WVE
Wave Life Sciences
NASDAQ
ALVO
Alvontech
USOTC
HDST
Headstrong (CE)
USOTC
WDBG
Woodbrook (PK)
NASDAQ
REKR
Rekor Systems
USOTC
HLSTF
Hallenstein Glasson (PK)
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지